LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 78 filers reported holding LEGEND BIOTECH CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,158,783 | -2.7% | 1,074,271 | 0.0% | 0.88% | +7.9% |
| Q2 2023 | $74,156,927 | +43.5% | 1,074,271 | +0.3% | 0.81% | +38.7% |
| Q1 2023 | $51,667,441 | -0.0% | 1,071,494 | +3.5% | 0.59% | -4.9% |
| Q4 2022 | $51,688,815 | +24.6% | 1,035,433 | +1.8% | 0.62% | +21.2% |
| Q3 2022 | $41,481,000 | +266.9% | 1,016,680 | +394.6% | 0.51% | +294.6% |
| Q2 2022 | $11,306,000 | +87.4% | 205,570 | +23.9% | 0.13% | +143.4% |
| Q1 2022 | $6,032,000 | +47.4% | 165,981 | +89.0% | 0.05% | +60.6% |
| Q4 2021 | $4,093,000 | -7.8% | 87,821 | 0.0% | 0.03% | -5.7% |
| Q3 2021 | $4,440,000 | +23.2% | 87,821 | 0.0% | 0.04% | +29.6% |
| Q2 2021 | $3,605,000 | +41.4% | 87,821 | 0.0% | 0.03% | +42.1% |
| Q1 2021 | $2,549,000 | -53.8% | 87,821 | -55.2% | 0.02% | -55.8% |
| Q4 2020 | $5,515,000 | +257.2% | 195,856 | +291.7% | 0.04% | +186.7% |
| Q3 2020 | $1,544,000 | -27.4% | 50,000 | 0.0% | 0.02% | -31.8% |
| Q2 2020 | $2,128,000 | – | 50,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |